Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Advances in Pharmacology (San Diego, Calif.)|July 6, 2026
Enhancing the persistence of therapeutic T cellsGregory M Chen, Joseph A FraiettaJournal for Immunotherapy of Cancer|May 8, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?Joseph A Fraietta, Jason J LohmuellerTrends in Molecular Medicine|June 16, 2020
First Trial of CRISPR-Edited T cells in Lung CancerSimon F Lacey, Joseph A FraiettaMolecular Cancer|March 19, 2022
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editingAlexander Dimitri, Friederike Herbst, Joseph A FraiettaCytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A FraiettaDiscovery Medicine|January 14, 2014
Immunotherapy with chimeric antigen receptors for multiple myelomaAlfred L Garfall, Joseph A Fraietta, Marcela V MausSeminars in Oncology|April 5, 2016
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsJoseph A Fraietta, Robert D Schwab, Marcela V MausSeminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.American Journal of Hematology|January 26, 2019
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancerSteven Feins, Weimin Kong, Erik F Williams, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Adoptive Cellular Therapy for Solid TumorsAdham S Bear, Joseph A Fraietta, Vivek K Narayan, et al.Pageof 12